On 26 June 2019, the French Council of State (‘Conseil d’État’) cancelled several provisions of the inter-ministerial Order of 4 May 2017 concerning the placing on […]
As a result of the entry into force of Regulation (EU) 2018/1532 concerning the non-renewal of diquat approval, ANSES has withdrawn 15 authorisations and 4 parallel […]
On 28 May 2019, Anses opinion on endocrine-disrupting properties of the active substance epoxiconazole was published and the withdrawal of marketing authorisations of epoxiconazole-based products was […]